Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...

although Amgen has also reported positive pivotal trial results in KRAS G12C-mutated colorectal cancer for Lumakras in combination with its own EGFR drug Vectibix (panitumumab). The CRC approval ...

KRAS G12C is the most common form of KRAS mutation in lung cancer, while G12D is found more commonly in other diseases like pancreatic and colorectal cancers. Dr Hu Tao, co-founder and chief ...

Learn more about whether Blueprint Medicines Corporation or Zai Lab Limited is a better investment based on AAII's A+ ...

Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Alexander I. Spira, MD, PhD, FACP, discusses the next steps in the clinical development of zoldonrasib for patients with KRAS ...

Alexander I. Spira, MD, PhD, FACP, discusses the clinical implications of ctDNA for treatment decisions and monitoring in ...

Dr. Christopher Flowers discusses MRD testing in cancer care, why this is an important concept to understand and how it relates to recurrence in patients. As someone who has overcome colorectal cancer ...

Scientists Discover How Excessive Red Meat Consumption Increases Colorectal Cancer Risk Oct. 23, 2024 — Scientists have uncovered a critical link between the overconsumption of red meat and an ...

There are many potential symptoms of colon cancer. Some are mild, and others may be more alarming. It’s important to speak with your doctor or healthcare professional if you have any of these ...

Peakstock - stock.adobe.com A new DNA test developed in the UK can accurately predict whether high-risk patients will develop colorectal cancer in the five years. People with inflammatory bowel ...